Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione

At Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione, much of the clinical trial activity focuses on kidney disease and related metabolic and immune system conditions. Studies are exploring new ways to slow disease progression, reduce protein loss in the urine, and preserve kidney function in patients with chronic and inherited renal disorders.

• Focal segmental glomerulosclerosis and IgA nephropathy
• Non-diabetic chronic kidney disease and broader renal decline
• Testing treatments aimed at improving proteinuria and long-term kidney outcomes

This research is especially relevant for patients living with progressive kidney conditions, with trials designed to evaluate whether new therapies can better protect renal function and improve day-to-day disease control.

The site also supports clinical research in neoplasms, with trials involving breast cancer, thyroid cancers, and urothelial cancer. These studies are examining whether newer cancer therapies can improve survival, strengthen the effect of standard treatment, and support better outcomes for people with advanced or high-risk disease.

• Breast cancer in the adjuvant setting
• Thyroid cancer and treatment before surgery
• Unresectable locally advanced or metastatic urothelial cancer

These trials reflect a strong interest in testing new cancer therapies, including approaches that may improve disease-free survival, extend overall survival, and refine treatment for patients with limited options.

Clinical trials at this Italian research site include work in cardiovascular diseases and nutritional and metabolic diseases. The research is aimed at understanding whether new therapies can reduce major heart-related events and better manage risk in people with chronic cardiometabolic conditions.

• Cardiovascular disease prevention and risk reduction
• Testing treatment effectiveness in people with heart and blood vessel disease
• Evaluating therapies for long-term metabolic and cardiovascular protection

This area of research is centered on improving protection against serious complications, with a focus on treatment benefit in routine clinical care.